Published in J Virol on May 01, 2004
The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol (2008) 1.19
The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev (2012) 1.12
The number of herpes simplex virus-infected neurons and the number of viral genome copies per neuron correlate with the latent viral load in ganglia. Virology (2007) 0.95
Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop? Cornea (2011) 0.93
Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal ganglia. J Virol (2009) 0.89
Influence of herpes simplex virus 1 latency-associated transcripts on the establishment and maintenance of latency in the ROSA26R reporter mouse model. J Virol (2012) 0.84
Ocular and neural distribution of feline herpesvirus-1 during active and latent experimental infection in cats. BMC Vet Res (2013) 0.82
Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus. Invest Ophthalmol Vis Sci (2011) 0.78
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol (1985) 8.12
Latent herpes simplex virus in spinal ganglia of mice. Science (1971) 7.04
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol (1989) 4.85
Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology (1990) 4.00
Detection of HSV-1 genome in central nervous system of latently infected mice. Nature (1983) 3.95
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol (1992) 3.56
Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science (2000) 3.51
Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol (1992) 2.90
A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J Virol (1997) 2.83
Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J Virol (1994) 2.41
Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol (1994) 2.27
The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol (1998) 2.18
Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol (2001) 2.17
Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology (1987) 2.05
A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol (1996) 1.94
The efficiency of simulation-based multiple comparisons. Biometrics (1987) 1.91
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J Virol (1998) 1.84
In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology (1995) 1.77
Spontaneous reactivation of experimental herpes simplex keratitis in rabbits. Arch Ophthalmol (1967) 1.61
The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits. J Virol (2000) 1.57
A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron (1990) 1.57
Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology (1993) 1.48
Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections. J Virol (1995) 1.37
Quantitation and kinetics of induced HSV-1 ocular shedding. Curr Eye Res (1986) 1.36
Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol (2003) 1.30
In situ polymerase chain reaction: localization of HSV-2 DNA sequences in infections of the nervous system. J Virol Methods (1994) 1.22
Spontaneous ocular shedding of HSV-1 in latently infected rabbits. Invest Ophthalmol Vis Sci (1985) 1.18
The effect of latency-associated transcript on the herpes simplex virus type 1 latency-reactivation phenotype is mouse strain-dependent. J Gen Virol (2001) 1.17
Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT region. J Virol (1993) 1.11
Herpes simplex virus genome replication and transcription during induced reactivation in the rabbit eye. J Virol (1997) 0.97
The region of the HSV-1 latency-associated transcript required for epinephrine-induced reactivation in the rabbit does not include the 2.0-kb intron. Virology (2002) 0.97
Pathogenesis and Molecular Biology of HSV Latency and Ocular Reactivation in the Rabbit. Methods Mol Med (1998) 0.90
Altering the expression kinetics of VP5 results in altered virulence and pathogenesis of herpes simplex virus type 1 in mice. J Virol (2002) 0.89
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science (1987) 11.14
Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J Virol (1983) 4.56
Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species. Virology (1980) 4.05
Characterization of herpes simplex virus type 1 RNA present in the absence of de novo protein synthesis. J Virol (1980) 4.01
Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology (1990) 4.00
Herpes simplex virus mRNA species mapping in EcoRI fragment I. J Virol (1982) 3.33
The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J Virol (1988) 3.22
Mesenteric Chyladenectasis: Report of a Case. Am J Pathol (1937) 3.13
A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology (1988) 3.11
Detailed characterization of the mRNA mapping in the HindIII fragment K region of the herpes simplex virus type 1 genome. J Virol (1981) 3.10
Herpes simplex virus type 1 HindIII fragment L encodes spliced and complementary mRNA species. J Virol (1981) 2.97
Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J Neurosci (2001) 2.97
Regulation of synthesis of herpes simplex type 1 virus mRNA during productive infection. Virology (1974) 2.94
RNA synthesis in cells infected with herpes simplex virus. II. Evidence that a class of viral mRNA is derived from a high molecular weight precursor synthesized in the nucleus. Proc Natl Acad Sci U S A (1969) 2.92
Quantitation of herpes simplex virus type 1 RNA in infected HeLa cells. J Virol (1977) 2.76
Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev (1997) 2.53
Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A (1989) 2.43
Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS. J Virol (1986) 2.41
Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J Virol (1994) 2.41
Characterization of a major late herpes simplex virus type 1 mRNA. J Virol (1981) 2.29
Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol (1994) 2.27
Ribonucleic acid synthesis in cells infected with herpes simplex virus. I. Patterns of ribonucleic acid synthesis in productively infected cells. J Virol (1969) 2.26
Isolation and localization of herpes simplex virus type 1 mRNA. J Virol (1979) 2.23
Relationship between polyadenylated and nonpolyadenylated herpes simplex virus type 1 latency-associated transcripts. J Virol (1991) 2.20
Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology (1983) 2.19
Isolation and localization of herpes simplex virus type 1 mRNA abundant before viral DNA synthesis. J Virol (1979) 2.16
Restricted transcription of the herpes simplex virus genome occurring early after infection and in the presence of metabolic inhibitors. Virology (1975) 2.09
High-resolution characterization of herpes simplex virus type 1 transcripts encoding alkaline exonuclease and a 50,000-dalton protein tentatively identified as a capsid protein. J Virol (1983) 2.07
Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. J Infect Dis (1988) 2.00
An unusual spliced herpes simplex virus type 1 transcript with sequence homology to Epstein-Barr virus DNA. J Virol (1985) 1.98
Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol (1988) 1.96
Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray. J Virol (2000) 1.95
A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol (1996) 1.94
Characterization of the genes encoding herpes simplex virus type 1 and type 2 alkaline exonucleases and overlapping proteins. J Virol (1986) 1.92
Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons. J Virol (1989) 1.85
Detailed characterization of an apparently unspliced beta herpes simplex virus type 1 gene mapping in the interior of another. J Virol (1982) 1.84
Effect of phorbol 12-myristate 13-acetate and its analogue 4 alpha-phorbol 12,13-didecanoate on protein phosphorylation and lysosomal enzyme release in rabbit neutrophils. J Biol Chem (1984) 1.80
The molecular size of the herpes simplex virus type 1 genome. Virology (1974) 1.78
L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA (1967) 1.78
Uninfected cell polymerase efficiently transcribes early but not late herpes simplex virus type 1 mRNA. Proc Natl Acad Sci U S A (1981) 1.76
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ (2013) 1.73
Molecular basis of the glycoprotein-C-negative phenotype of herpes simplex virus type 1 macroplaque strain. J Virol (1984) 1.71
Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res (1987) 1.70
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun (1997) 1.69
Further properties of the diamine oxidase of pea seedlings. Biochem J (1964) 1.63
The regional distribution and cellular localization of iron in the rat brain. Neuroscience (1984) 1.62
Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos (1993) 1.61
Responses of group III and IV muscle afferents to dynamic exercise. J Appl Physiol (1985) (1997) 1.60
Mapping early transcripts of herpes simplex virus type 1 by electron microscopy. J Virol (1978) 1.56
New procedures for purification of L-asparaginase with high yield from Escherichia coli. J Bacteriol (1968) 1.55
Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly. J Virol (1991) 1.54
Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther (2001) 1.52
Transcription of the herpes simplex virus genome in human cells. J Virol (1972) 1.52
Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology (1990) 1.51
Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. J Virol (1985) 1.45
Characterization of the DNA of herpesviruses associated with Lucké adenocarcinoma of the frog and Burkitt lymphoma of man. Virology (1970) 1.45
Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun (1994) 1.45
Xeroderma pigmentosum cells contain low levels of photoreactivating enzyme. Proc Natl Acad Sci U S A (1975) 1.43
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A (1986) 1.43
The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med (1996) 1.41
Rhabdomyolysis and a "greenhouse effect". Lancet (1990) 1.38
Time-saving formats for patient care planning in outpatient surgery units. J Post Anesth Nurs (1991) 1.37
Quantitation and kinetics of induced HSV-1 ocular shedding. Curr Eye Res (1986) 1.36
Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc Natl Acad Sci U S A (1985) 1.35
HSV-1 shedding by lontophoresis of 6-hydroxydopamine followed by topical epinephrine. Invest Ophthalmol Vis Sci (1983) 1.31
Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci (1991) 1.30
Visualization and characterization of interleukin 1 receptors in brain. J Immunol (1987) 1.30
Mutational analysis of the herpes simplex virus type 1 strict late UL38 promoter/leader reveals two regions critical in transcriptional regulation. J Virol (1993) 1.29
Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J Toxicol Environ Health A (2011) 1.28
Effects of contraction and lactic acid on the discharge of group III muscle afferents in cats. J Neurophysiol (1993) 1.27
Long-term promoter activity during herpes simplex virus latency. J Virol (1994) 1.27
Evidence for transcriptional control of the herpes simplex virus genome in infected human cells. Virology (1972) 1.26
A major portion of the latent pseudorabies virus genome is transcribed in trigeminal ganglia of pigs. J Virol (1990) 1.25
Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience (1986) 1.25
Chemical studies on amino acid acceptor ribonucleic acids. VII. Partial ribonuclease digestion of alanine and valine soluble ribonucleic acid from yeast. Biochemistry (1966) 1.25
The herpes simplex virus type 1 reactivation function lies outside the latency-associated transcript open reading frame ORF-2. J Virol (1993) 1.25
Biochemical and genetic evidence for a new class of emetine-resistant Chinese hamster cells with alterations in the protein biosynthetic machinery. Somatic Cell Genet (1980) 1.25
Response to highly purified L-asparaginase during therapy of acute leukemia. Cancer Res (1969) 1.24
The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res (1990) 1.23
The molecular weight of yeast P1 double-stranded RNA. J Biol Chem (1978) 1.23
Genetic characterization of pyridine nucleotide uptake mutants of Salmonella typhimurium. J Gen Microbiol (1985) 1.22
5'-Terminal and internal methylated nucleosides in herpes simplex virus type 1 mRNA. J Virol (1977) 1.21
Transcriptional analysis of the herpes simplex virus type 1 region containing the TRL/UL junction. Virology (1993) 1.21
Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer. Eur J Cancer Clin Oncol (1986) 1.21
Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell (2001) 1.20
Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci (1996) 1.20
Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes (2001) 1.20
Isolation and translation of mRNA encoded by a specific region of the herpes simplex virus type 1 genome. J Virol (1980) 1.20
Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J (1992) 1.20
Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci Lett (2010) 1.19
A single regulatory region modulates both cis activation and trans activation of the herpes simplex virus VP5 promoter in transient-expression assays in vivo. J Virol (1986) 1.18
Spontaneous ocular shedding of HSV-1 in latently infected rabbits. Invest Ophthalmol Vis Sci (1985) 1.18
An analysis of air transport results in the sick newborn II. Antenatal and neonatal referrals. Am J Obstet Gynecol (1977) 1.16
The kinetics of expression of individual herpes simplex virus type 1 transcripts. Virus Genes (1987) 1.15